(Q35131803)

6 August 2017

title

Toward protecting the safety of participants in clinical trials (English)

1 reference

6 August 2017

8

Jeremy Sugarman

1 reference

6 August 2017

1

Robert M Califf

1 reference

6 August 2017

Michael A Morse

2

1 reference

6 August 2017

Janet Wittes

3

1 reference

6 August 2017

Steven N Goodman

4

1 reference

6 August 2017

Daniel K Nelson

5

1 reference

6 August 2017

David L DeMets

6

1 reference

6 August 2017

R Peter Iafrate

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Contemporary Clinical Trials

6 August 2017

published in

1 reference

6 August 2017

volume

24

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

256-271

1 reference

Improving protection for research subjects.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Monitoring and ensuring safety during clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Clinical research. Flawed cancer study leads to shake-up at University of Oklahoma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Institutional review boards: a crisis in confidence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Variation in institutional review board responses to a standard protocol for a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Should all trials have a data safety and monitoring committee?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

A central institutional review board for multi-institutional trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

The role of institutional support in protecting human research subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

The Data and Safety Monitoring Committee: Some final thoughts.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Developing systems for cost-effective auditing of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Can investigator certification improve the quality of clinical research?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

Improving informed consent in clinical trials: a duty to experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2803%2900005-9

7 January 2021

10.1016/S0197-2456(03)00005-9

Identifiers

DOI

1 reference

6 August 2017

1 reference